Touchlight and GSK Partner for Enzymatic dbDNA Production in mRNA Manufacturing

Touchlight, a contract development and manufacturing organization (CDMO) specializing in enzymatic DNA production, has entered into a licensing agreement with …

Continue ›››

The Synergistic Potential of AI and Synthetic Biology: Interview with S&P Global’s Miriam Fernández

The rapid convergence of artificial intelligence (AI) and synthetic biology (synbio) is set to revolutionize a multitude of industries, ranging …

Continue ›››

Abiologics Emerges to Introduce New Class of Biologic Drugs

Flagship Pioneering, a bioplatform innovation company, has announced the launch of Abiologics, a new venture focused on revolutionizing the field …

Continue ›››

Proscia Introduces Enhanced Concentriq AP with Multi-AI Workflows for Pathology

Proscia, a provider of AI-powered pathology solutions for precision medicine, has announced an update to its Concentriq AP platform. The …

Continue ›››

New Insurance Model Could Transform Clinical Trial Financing

A novel initiative by Medical and Commercial International Limited (MCI) and GATC Health Corp, supported by Lloyd's of London, promises …

Continue ›››

Biotech Trends to Watch: Reflecting on the First Half of 2024

If we talk about tech advances in pharma and biotech, the year 2024 has been a blast so far! Last …

Continue ›››

New Liquid Biopsy Method Enables Monitoring of Disease Evolution in Metastatic Prostate Cancer Patients

A new liquid biopsy approach enables monitoring of disease evolution in patients with metastatic prostate cancer through the analysis of …

Continue ›››

10 Notable Biotech Companies With Recent Major VC Rounds

As the biotech sector recovers to pre-COVID investment levels, venture capital firms have become more selective in their funding choices. …

Continue ›››

Accidental Breakthrough in Aging Research

Recent research reveals that blocking an inflammation-promoting protein, IL-11, can significantly extend the lifespan and improve the health of laboratory …

Continue ›››

Artiva Biotherapeutics Lowers IPO Price, Raises $167 Million for Autoimmune Therapies

Artiva Biotherapeutics, a clinical-stage biotechnology company, has raised $167 million through its initial public offering (IPO). The company offered 13.9 …

Continue ›››

SkyCell and Validaide Team Up to Reduce Carbon Emissions in Pharmaceutical Supply Chains

SkyCell, a technology company specializing in the pharmaceutical supply chain, has partnered with Validaide, a lane risk assessment platform, to …

Continue ›››

Integra Therapeutics Secures €10.5 Million from European Commission for FiCAT Advanced Therapies Platform

Integra Therapeutics, a biotech company specializing in gene writing tools, has been awarded a grant and equity investment totaling €10.5 …

Continue ›››